Company Data
MiNK Therapeutics Inc.
Ticker
INKT
Current Price
$14.21 0.57%
Market Cap
$70.6M
Price Target
Refer to Report
Volume
147.6K
52wk Range
$6.34 - $76
Overview
MiNK Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing allogeneic invariant natural killer T cell therapies to treat cancer and other life-threatening illnesses.